Lupin gets CDSCO panel okay to manufacture, market tuberculosis drug Rifapentine Dr. Divya Colin5 March 2022 5:35 PM ISTNew Delhi: Drug major, Lupin has got a go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization to (CDSCO)...
Panacea Biotec gets CDSCO nod Pentavalent vaccine for 5 deadly disease Dr. Divya Colin1 March 2022 5:20 PM ISTNew Delhi: In a significant development, Panacea Biotec has got approval from the Subject Expert Committee (SEC) functional under the Central Drugs...
Cipla gets CDSCO panel okay to manufacture, market Metformin, Sitagliptin FDC Susmita Roy28 Feb 2022 1:19 PM ISTNew Delhi: Pharmaceutical major, Cipla has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Cipla gets CDSCO panel green signal to conduct Paxlovid trials in India Roshni Dhar28 Feb 2022 12:10 PM ISTIn a significant development, drug-major Cipla has got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Sun Pharma gets CDSCO panel nod to conduct phase 4 study of Cyclosporine Ophthalmic Solution Dr. Divya Colin27 Feb 2022 10:00 AM ISTNew Delhi: Pharmaceutical major, Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Health Bulletin 26/February/2022 Roshni Dhar26 Feb 2022 4:13 PM ISTHere are top health stories for the dayIndia fears for its children as thousands of MBBS students stuck in Ukraine Amid the growing...
Cipla gets CDSCO panel nod to conduct Indian trials of Paxlovid Dr. Divya Colin26 Feb 2022 12:06 PM ISTNew Delhi: In a significant development, drug-major Cipla has got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard...
Novartis bags CDSCO panel nod for Phase 3 trial of Secukimunab Roshni Dhar24 Feb 2022 6:28 PM ISTThe pharmaceutical major, Novartis, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Health Bulletin 24/February/2022 Roshni Dhar24 Feb 2022 6:23 PM ISTHere are top health stories for the dayFORDA demands action against hospitals for not paying salaries to doctorsThe Federation of Resident Doctors...
Novartis gets CDSCO panel okay for phase 3 trial of Secukimunab Dr. Divya Colin23 Feb 2022 3:10 PM ISTNew Delhi: The pharmaceutical major, Novartis, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Intas pharma gets CDSCO panel nod to manufacture, market schizophrenia drug Clozapine Susmita Roy21 Feb 2022 5:00 PM ISTNew Delhi: Pharmaceutical major Intas Pharmaceuticals has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Submit in vitro data on safety of Ropivacaine HCL monohydrate delivery: CDSCO panel tells Cipla Dr. Divya Colin20 Feb 2022 12:30 PM ISTNew Delhi: In line with the pharma major Cipla's Phase III clinical trial data for the local anaesthetic drug Ropivacaine HCL monohydrate solution for...
